Cargando…
The Development of Peptide-based Antimicrobial Agents against Dengue Virus
Dengue fever has become an imminent threat to international public health because of global warming and climate change. The World Health Organization proclaimed that more than 50% of the world’s population is at risk of dengue virus (DENV) infection. Therefore, developing a clinically ap-proved vacc...
Autores principales: | Huang, Yen-Wei, Lee, Chun-Ting, Wang, Ta-Chen, Kao, Yun-Chung, Yang, Chih-Hui, Lin, Yu-Mei, Huang, Keng-Shiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446661/ https://www.ncbi.nlm.nih.gov/pubmed/29852867 http://dx.doi.org/10.2174/1389203719666180531122724 |
Ejemplares similares
-
Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus
por: Rothan, Hussin A, et al.
Publicado: (2014) -
Peptides as Therapeutic Agents for Dengue Virus
por: Chew, Miaw-Fang, et al.
Publicado: (2017) -
Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection
por: Lai, Yen-Chung, et al.
Publicado: (2017) -
Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
por: Lee, Chun-Ting, et al.
Publicado: (2015) -
Cyclooxygenase‐2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents
por: Lin, Chun-Kuang, et al.
Publicado: (2017)